4 months progress on fin/min - so happy with it Progress Pictures 7/14/2026
A user shared their 4-month progress using oral finasteride and minoxidil, reporting significant hair regrowth with no noticeable side effects. They used a blend from HIMS, including additional vitamins and minerals, and addressed concerns about lighting differences in photos.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity M40 - 3 Months progress on Fin/Min
A user reported significant hair regrowth after 3 months using 1mg oral finasteride, 1ml 5% topical minoxidil, and microneedling, along with biotin, vitamin D, iron, and zinc supplements. They are optimistic about continued progress despite initial skepticism.
community Finasteride 1MG and Minoxidil for 3.5 years. Scary diffuse shedding.
The user has been experiencing significant hair shedding despite using finasteride and minoxidil for 3.5 years. They suspect the shedding could be due to stress, medication changes, or other factors, and are considering blood tests and additional treatments like oral minoxidil and serums.
community 16 months finasteride & minoxidil progress
User shared 16-month progress using finasteride 1 mg/day and minoxidil 5% solution once/day, noting significant regrowth, especially in temporal peaks. Users discussed shedding, side effects, and positive feedback from others.
community 10 months, a new person. Propecia oral minoxidil topical
A user shared their 10-month hair loss progress using Propecia, oral minoxidil, and topical minoxidil. The results were highly praised, with requests for more details on dosages and routine.
community 25M (2.5mg Oral Min + 1mg Oral Fin Daily)
A 25-year-old male is experiencing improved hair density after 4 months on oral minoxidil (2.5 mg) and 2 months on oral finasteride (1 mg) with no side effects. He is encouraged by the progress and plans to continue the treatment, considering additional methods like microneedling and PRP for further improvement.
Related Research
6 / 6 results
research Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
This review of real-world treatment options for AA indicates that current therapies are insufficient, with high dissatisfaction rates, highlighting a need for improved solutions.
research Digital health platforms expand access and improve care for male androgenetic alopecia
In this study, patients using the digitally enabled platform Keeps for male pattern hair loss treatment reported positive health outcomes, with 81% experiencing hair regrowth or ceasing hair loss after six months.
research Comparison of Microneedling with Platelet Rich Plasma vs Minoxidil (5%)+Finasteride (0.1%) Topical Therapy in Androgenetic Alopecia: A Randomised Clinical Study
This study compared the effectiveness and safety of microneedling with PRP versus minoxidil and finasteride topical therapy in adult males with androgenetic alopecia, finding similar hair density improvements in both groups, though microneedling with PRP had a quicker onset of action.
research Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint)
This study observed that patients using a novel topical combination of finasteride and minoxidil for male androgenetic alopecia reported high satisfaction and good tolerance, with few side effects and no need for higher-level care, despite limitations such as retrospective data and no control group.
research Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint)
In this large retrospective study, patients using compounded topical finasteride and minoxidil through a telehealth platform for male androgenetic alopecia reported high satisfaction and low incidence of side effects, with no need for higher care or treatment discontinuation due to adverse reactions.
research Response to Ranpariya et al.’s “Direct-to-consumer teledermatology platforms may have inherent conflicts of interest.”
This article discusses various limitations of direct-to-consumer teledermatology platforms, highlighting concerns regarding ethical issues, financial conflicts of interest, and challenges in providing comprehensive patient care compared to traditional in-person consultations.